Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.75 |
| ▸ | MAPT | P10636 | 8/20 | 0.75 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.75 |
| ▸ | FTO | Q9C0B1 | 6/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.75 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.75 |
| ▸ | XDH | P47989 | 5/20 | 0.75 |
| ▸ | APP | P05067 | 5/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.75 |
| ▸ | CA12 | O43570 | 4/20 | 0.75 |
| ▸ | TRPC5 | Q9UL62 | 4/20 | 0.75 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.75 |
| ▸ | BCHE | P06276 | 4/20 | 0.75 |
| ▸ | ACHE | P22303 | 4/20 | 0.75 |
| ▸ | PPARG | P37231 | 3/20 | 0.75 |
| ▸ | CA7 | P43166 | 3/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Galangin SCHEMBL7926038 | 0.94 | MEN1 (0.85) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Morin SCHEMBL2118429 | 0.93 | MEN1 (0.75) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Kaempferol SCHEMBL1485787 | 0.91 | MEN1 (0.79) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Kaempferol SCHEMBL31164054 | 0.91 | MEN1 (0.79) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Myricetin SCHEMBL2278240 | 0.90 | MEN1 (0.77) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Quercetin SCHEMBL111510 | 0.88 | MEN1 (0.76) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Galangin SCHEMBL29393121 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Galangin SCHEMBL117225 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Datiscetin SCHEMBL43916 | 0.87 | APP (1.00) | MEN1KMT2ACYP3A4MAPTABCB1 | |
| Datiscetin SCHEMBL29737517 | 0.87 | APP (1.00) | MEN1KMT2ACYP3A4MAPTABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140135359-A1 | METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES | MARTINEAU LOUIS C (CA) | 2014-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135359-A1 | METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES | UQCRC2, UQCRC1, TIMM50 | MEN1 1092/4885KMT2A 3551/4885CYP3A4 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.